FDA Clears CDC's Dengue MDx Test | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing a test for dengue virus developed by the US Centers for Disease Control and Prevention, CDC said today.

The test is the first FDA-approved molecular test for dengue and uses real-time PCR technology. Called the CDC DENV-1-4 Real Time RT PCR Assay, it can detect dengue within the first seven days after symptoms appear and can detect all four dengue virus types, CDC said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.